[Considerations on the bacterial flora in patients with infections of the respiratory tract and in immunosuppressed patients (author's transl)]. 1976

A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi

Epidemiological features of pathogenic mycetes have been investigated with regard to their relationship with bacterial flora in patients with acute and chronic bronchopulmonary diseases and in immunosuppressed patients. Opportunistic mycetes (Candida and Aspergillus) have been found frequently associated with Gram-negative pathogenic bacteria. In immunosuppressed patients, the plenty of mycetic flora is related to the degree of immunoglobulin deficiency especially to the IgG and IgA levels.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009343 Neisseria A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
January 1994, Medycyna doswiadczalna i mikrobiologia,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
January 1976, Annali Sclavo; rivista di microbiologia e di immunologia,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
September 1973, Medizinische Klinik,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
January 1976, Annali Sclavo; rivista di microbiologia e di immunologia,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
December 1979, Mykosen,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
January 1981, Infection,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
August 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
April 1983, Pediatria polska,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
January 1980, Revue francaise des maladies respiratoires,
A Lechi, and I Piacentini, and S Biondani, and E Arosio, and G Montesi, and C Mengoli, and U Bonomi
January 1982, Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia,
Copied contents to your clipboard!